摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-fluoro-N-[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

中文名称
——
中文别名
——
英文名称
2-fluoro-N-[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
英文别名
——
2-fluoro-N-[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide化学式
CAS
——
化学式
C8H14FNO6
mdl
——
分子量
239.2
InChiKey
LMPCEKTVFVQIPT-QUFICUBGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    119
  • 氢给体数:
    5
  • 氢受体数:
    7

文献信息

  • CHEMOENZYMATIC SYNTHESIS OF HEPARIN AND HEPARAN SULFATE ANALOGS
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US20140235575A1
    公开(公告)日:2014-08-21
    The present invention provides a one-pot multi-enzyme method for preparing UDP-sugars from simple sugar starting materials. The invention also provides a one-pot multi-enzyme method for preparing oligosaccharides from simple sugar starting materials.
    本发明提供了一种一锅多酶法,用于从简单糖起始材料制备UDP糖。该发明还提供了一种一锅多酶法,用于从简单糖起始材料制备寡糖
  • DEPRESSION TREATMENT AGENT
    申请人:THE UNIVERSITY OF TOKYO
    公开号:US20170080004A1
    公开(公告)日:2017-03-23
    The invention provides an agent for treating depression, which contains N-acetyl-D-mannosamine, and a pharmaceutical composition for treating depression, which contains an effective amount of N-acetyl-D-mannosamine and a carrier acceptable as a medicament.
  • GLUCOSE-SENSITIVE CELL PROTECTING AGENT
    申请人:THE UNIVERSITY OF TOKYO
    公开号:US20180085385A1
    公开(公告)日:2018-03-29
    The invention provides an agent containing N-acetyl-D-mannosamine for protecting a glucose-sensitive cell from glucose toxicity due to high glucose concentration; a pharmaceutical composition for protecting a glucose-sensitive cell from glucose toxicity due to high glucose concentration, containing an effective amount of N-acetyl-D-mannosamine and a pharmaceutically acceptable carrier; use of N-acetyl-D-mannosamine in producing a medicament for protecting a glucose-sensitive cell from glucose toxicity due to high glucose concentration; and a method of protecting a glucose-sensitive cell from glucose toxicity due to high glucose concentration, including administering an effective amount of N-acetyl-D-mannosamine to a subject in need thereof. The glucose-sensitive cell is selected from the group consisting of a nerve cell, a renal cell and a vascular endothelial cell.
  • US9290530B2
    申请人:——
    公开号:US9290530B2
    公开(公告)日:2016-03-22
  • US9968624B2
    申请人:——
    公开号:US9968624B2
    公开(公告)日:2018-05-15
查看更多